Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

27.37
BATS BZX Real-Time Price
As of 2:04pm ET
 +0.18 / +0.66%
Today’s Change
18.52
Today|||52-Week Range
43.76
-9.22%
Year-to-Date
3 Bold Bets on the Future of Biotechnology
Sep 25 / MotleyFool.com - Paid Partner Content
Here's Why Food Security May Be One of the Best Investments of the 21st Century
Sep 17 / MotleyFool.com - Paid Partner Content
Better Buy: Ziopharm Oncology, Inc. vs. Alnylam Pharmaceuticals, Inc.
Sep 24 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close27.19
Today’s open27.13
Day’s range26.99 - 27.75
Volume38,846
Average volume (3 months)1,532,815
Market cap$3.2B
Dividend yield--
Data as of 2:04pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)+8.43%
Earnings growth (this year)-88.60%
Earnings growth (next 5 years)-78.25%
Revenue growth (last year)+141.35%
P/E ratioNM
Price/Sales19.29
Price/Book4.57

Competitors

 Today’s
change
Today’s
% change
JUNOJuno Therapeutics In...+3.80+12.82%
KITEKite Pharma Inc+4.65+8.46%
ARIAARIAD Pharmaceutical...0.000.00%
BLUEbluebird bio Inc+2.30+3.23%
Data as of 2:07pm ET, 09/27/2016

Financials

Next reporting dateNovember 10, 2016
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$173.6M
Annual profit (last year)-$84.5M
Net profit margin-48.67%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Randal J. Kirk
President
Geno J. Germano
Corporate headquarters
Germantown, Maryland

Forecasts

Search for Jobs